These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38146130)

  • 1. A new predictive parameter for dose-volume metrics in intensity-modulated radiation therapy planning for prostate cancer: Initial phantom study.
    Saito Y; Suzuki R; Miyamoto N; Sutherland KL; Kanehira T; Tamura M; Mori T; Nishioka K; Hashimoto T; Aoyama H
    J Appl Clin Med Phys; 2024 Apr; 25(4):e14250. PubMed ID: 38146130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A predictive model for determining rectum and bladder dose constraints in prostate volumetric modulated arc therapy.
    Chao M; Coburn N; Cosgriff E; Brown C; Van Tilburg K; Hayden A
    Med Dosim; 2021 Autumn; 46(3):269-273. PubMed ID: 33726940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.
    Yin L; Wu H; Gong J; Geng JH; Jiang F; Shi AH; Yu R; Li YH; Han SK; Xu B; Zhu GY
    World J Gastroenterol; 2012 Oct; 18(37):5266-75. PubMed ID: 23066322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
    Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
    Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of volumetric-modulated arc therapy and intensity-modulated radiation therapy prostate cancer plans accounting for cold spots.
    Nguyen TTT; Arimura H; Asamura R; Hirose TA; Ohga S; Fukunaga JI
    Radiol Phys Technol; 2019 Jun; 12(2):137-148. PubMed ID: 30805779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volumetric-modulated arc therapy for the treatment of a large planning target volume in thoracic esophageal cancer.
    Abbas AS; Moseley D; Kassam Z; Kim SM; Cho C
    J Appl Clin Med Phys; 2013 May; 14(3):4269. PubMed ID: 23652258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer.
    Da Silva Mendes V; Nierer L; Li M; Corradini S; Reiner M; Kamp F; Niyazi M; Kurz C; Landry G; Belka C
    Radiat Oncol; 2021 Jul; 16(1):133. PubMed ID: 34289868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving plan quality for prostate volumetric-modulated arc therapy.
    Wright K; Ferrari-Anderson J; Barry T; Bernard A; Brown E; Lehman M; Pryor D
    Med Dosim; 2017 Winter; 42(4):348-356. PubMed ID: 28784431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric comparison of two treatment planning systems for spine SBRT.
    Lee YK; Munawar I; Mashouf S; Sahgal A; Ruschin M
    Med Dosim; 2020 Spring; 45(1):77-84. PubMed ID: 31376988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dosimetric comparison of intensity-modulated radiotherapy versus rapid arc in gynecological malignancies: Dose beyond planning target volume, precisely 5Gy volume.
    Sidhu MS; Singh K; Sood S; Aggarwal R
    J Cancer Res Ther; 2023; 19(5):1267-1271. PubMed ID: 37787294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target miss using PTV-based IMRT compared to robust optimization via coverage probability concept in prostate cancer.
    Outaggarts Z; Wegener D; Berger B; Zips D; Paulsen F; Bleif M; Thorwarth D; Alber M; Dohm O; Müller AC
    Acta Oncol; 2020 Aug; 59(8):911-917. PubMed ID: 32436467
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans.
    Yuan L; Ge Y; Lee WR; Yin FF; Kirkpatrick JP; Wu QJ
    Med Phys; 2012 Nov; 39(11):6868-78. PubMed ID: 23127079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous integrated boost plan comparison of volumetric-modulated arc therapy and sliding window intensity-modulated radiotherapy for whole pelvis irradiation of locally advanced prostate cancer.
    Riou O; Regnault de la Mothe P; Azria D; Aillères N; Dubois JB; Fenoglietto P
    J Appl Clin Med Phys; 2013 Jul; 14(4):4094. PubMed ID: 23835376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapy.
    Rana S; Cheng C; Zheng Y; Hsi W; Zeidan O; Schreuder N; Vargas C; Larson G
    J Appl Clin Med Phys; 2014 May; 15(3):4611. PubMed ID: 24892333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An improved distance-to-dose correlation for predicting bladder and rectum dose-volumes in knowledge-based VMAT planning for prostate cancer.
    Wall PDH; Carver RL; Fontenot JD
    Phys Med Biol; 2018 Jan; 63(1):015035. PubMed ID: 29131812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of photon-beam energy on VMAT and IMRT treatment plan quality and dosimetric accuracy for advanced prostate cancer.
    Pasler M; Georg D; Wirtz H; Lutterbach J
    Strahlenther Onkol; 2011 Dec; 187(12):792-8. PubMed ID: 22127357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VMAT partial arc technique decreases dose to organs at risk in whole pelvic radiotherapy for prostate cancer when compared to full arc VMAT and IMRT.
    Bartlett GK; Njeh CF; Huang KC; DesRosiers C; Guo G
    Med Dosim; 2023 Spring; 48(1):8-15. PubMed ID: 36319515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer.
    Davidson MT; Blake SJ; Batchelar DL; Cheung P; Mah K
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1550-8. PubMed ID: 21543164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
    Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dosimetric comparison of volumetric modulated arc therapy (VMAT) and non-coplanar intensity modulated radiotherapy (IMRT) for nasal cavity and paranasal sinus cancer.
    Jeong Y; Lee SW; Kwak J; Cho I; Yoon SM; Kim JH; Park JH; Choi EK; Song SY; Kim YS; Kim SS; Joo JH; Ahn SD
    Radiat Oncol; 2014 Aug; 9():193. PubMed ID: 25175383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.